AcelRx Pharmaceuticals Competitors
| Ticker | Name | Consensus | Stock Rating | Price | Buy/Sell | Price Target | Upside/Downside | Analysts | Market Cap |
|---|---|---|---|---|---|---|---|---|---|
| JNJ | Johnson & Johnson | Outperform |
9
|
$154.64 | Buy/Sell | $174.55 | 9.93% | 3 | $372.17B |
| SUPN | Supernus Pharmaceuticals | Outperform |
16
|
$29.10 | Buy/Sell | $41.00 | 40.89% | 0 | $1.72B |
| ANIP | ANI Pharmaceuticals | Buy |
13
|
$61.43 | Buy/Sell | $69.75 | 30.23% | 1 | $1.38B |
| IRWD | Ironwood Pharmaceuticals | Buy |
14
|
$6.48 | Buy/Sell | $17.83 | 139.20% | 2 | $1.29B |
| COLL | Collegium Pharmaceutical | Outperform |
11
|
$32.47 | Buy/Sell | $37.75 | 23.19% | 1 | $1.24B |
| PCRX | Pacira BioSciences | Outperform |
16
|
$30.82 | Buy/Sell | $47.90 | 42.76% | 6 | $1.23B |
| HRTX | Heron Therapeutics | Buy |
7
|
$3.20 | Buy/Sell | $5.63 | 103.13% | 0 | $442.92M |
| AQST | Aquestive Therapeutics | Buy |
0
|
$3.11 | Buy/Sell | $6.33 | 189.39% | 0 | $307.71M |
| ZVRA | Zevra Therapeutics | Buy |
10
|
$4.73 | Buy/Sell | $19.50 | 291.12% | 1 | $204.66M |
| DRRX | DURECT | Outperform |
9
|
$0.93 | Buy/Sell | $6.75 | 813.98% | 2 | $33.21M |
| CPIX | Cumberland Pharmaceuticals | - |
0
|
$2.03 | Buy/Sell | $8.50 | -100.00% | 0 | $24.38M |
| TRVN | Trevena | Outperform |
2
|
$0.61 | Buy/Sell | $5.18 | 555.74% | 0 | $9.38M |
| BXRX | Baudax Bio | - |
0
|
$0.01 | Buy/Sell | $24.00 | -100.00% | 0 | $1.16M |
| ACOR | Acorda Therapeutics | - |
5
|
$0.43 | Buy/Sell | $200.00 | -100.00% | 1 | $0.53M |
| DMK | DMK Pharmaceuticals | - |
8
|
$0.03 | Buy/Sell | $1.50 | -100.00% | 0 | $0.35M |